Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Naomi Kashima

Preclinical and First-In-Human Phase I Studies of KW-2450, an Oral Tyrosine Kinase Inhibitor With Insulin-Like Growth Factor Receptor-1/Insulin Receptor Selectivity

Cancer Science

English

Related publications

Insulin-Like Growth Factor-I Receptor Blockade by a Specific Tyrosine Kinase Inhibitor for Human Gastrointestinal Carcinomas

Molecular Cancer Therapeutics

Cancer Research

Oncology

2008

English

Preclinical and Phase I Clinical Studies of KW-2450, a Dual IGF-1R/IR Tyrosine Kinase Inhibitor, in Combination With Lapatinib and Letrozole

Therapeutic Advances in Medical Oncology

Oncology

2018

English

GβγSubunits Mediate Mitogen-Activated Protein Kinase Activation by the Tyrosine Kinase Insulin-Like Growth Factor 1 Receptor

Journal of Biological Chemistry

English

Clinical Phase I Study With an Insulin-Like Growth Factor-1 Receptor Inhibitor: Experiences in Patients With Squamous Non-Small Cell Lung Carcinoma

English

Insulin Receptor Substrate-2 Mediated Insulin-Like Growth Factor-I Receptor Overexpression in Pancreatic Adenocarcinoma Through Protein Kinase C

Cancer Research

Oncology

2009

English

C-Terminal SRC Kinase Associates With Ligand-Stimulated Insulin-Like Growth Factor-I Receptor

Journal of Biological Chemistry

English

Insulin-Like Growth Factor-I-Induced DNA Synthesis in Insulin-Secreting Cell Line RINm5F Is Associated With Phosphorylation of the Insulin-Like Growth Factor-I Receptor and the Insulin Receptor Substrate-2

Journal of Endocrinology

English

Antiapoptotic Signalling by the Insulin-Like Growth Factor I Receptor, Phosphatidylinositol 3-Kinase, and Akt.

Molecular and Cellular Biology

Cell Biology

Molecular Biology

1997

English

Mutational Analysis of the Insulin-Like Growth Factor 1 Receptor Tyrosine Kinase Domain in Non-Small Cell Lung Cancer Patients

Molecular and Clinical Oncology

Cancer Research

Oncology

2015

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Naomi Kashima

Preclinical and First-In-Human Phase I Studies of KW-2450, an Oral Tyrosine Kinase Inhibitor With Insulin-Like Growth Factor Receptor-1/Insulin Receptor Selectivity

Related publications

Insulin-Like Growth Factor-I Receptor Blockade by a Specific Tyrosine Kinase Inhibitor for Human Gastrointestinal Carcinomas

Preclinical and Phase I Clinical Studies of KW-2450, a Dual IGF-1R/IR Tyrosine Kinase Inhibitor, in Combination With Lapatinib and Letrozole

GβγSubunits Mediate Mitogen-Activated Protein Kinase Activation by the Tyrosine Kinase Insulin-Like Growth Factor 1 Receptor

Clinical Phase I Study With an Insulin-Like Growth Factor-1 Receptor Inhibitor: Experiences in Patients With Squamous Non-Small Cell Lung Carcinoma

Insulin Receptor Substrate-2 Mediated Insulin-Like Growth Factor-I Receptor Overexpression in Pancreatic Adenocarcinoma Through Protein Kinase C

C-Terminal SRC Kinase Associates With Ligand-Stimulated Insulin-Like Growth Factor-I Receptor

Insulin-Like Growth Factor-I-Induced DNA Synthesis in Insulin-Secreting Cell Line RINm5F Is Associated With Phosphorylation of the Insulin-Like Growth Factor-I Receptor and the Insulin Receptor Substrate-2

Antiapoptotic Signalling by the Insulin-Like Growth Factor I Receptor, Phosphatidylinositol 3-Kinase, and Akt.

Mutational Analysis of the Insulin-Like Growth Factor 1 Receptor Tyrosine Kinase Domain in Non-Small Cell Lung Cancer Patients